You are here
Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease
, “Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease”, Proteins: Structure, Function, and Bioinformatics, vol. 89, pp. 1425-1441, 2021.